Company Arsanis Inc Nasdaq
Equities
US0428731097
Biotechnology & Medical Research
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Paula Ragan
FOU | Founder | 54 | 01/10/01 |
Adam Mostafa
DFI | Director of Finance/CFO | 44 | 01/18/01 |
Mary DiBiase
COO | Chief Operating Officer | 63 | 01/17/01 |
Chief Tech/Sci/R&D Officer | - | 01/23/01 | |
Art Taveras
CTO | Chief Tech/Sci/R&D Officer | 60 | 02/20/02 |
Murray Stewart
BRD | Director/Board Member | 63 | 29/19/29 |
Brian Bowersox
PRN | Corporate Officer/Principal | - | - |
Mark Baldry
PRN | Corporate Officer/Principal | - | 26/22/26 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Michael Wyzga
CHM | Chairman | 69 | 01/18/01 |
David McGirr
BRD | Director/Board Member | 69 | 01/17/01 |
Paula Ragan
FOU | Founder | 54 | 01/10/01 |
Gary Bridger
BRD | Director/Board Member | 61 | 01/18/01 |
Alison Lawton
BRD | Director/Board Member | 62 | 05/20/05 |
Bill Aliski
BRD | Director/Board Member | 75 | 18/19/18 |
Director/Board Member | 62 | 14/21/14 | |
Murray Stewart
BRD | Director/Board Member | 63 | 29/19/29 |
R. Woods
BRD | Director/Board Member | 57 | 16/23/16 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 167,937,781 | 162,995,043 ( 97.06 %) | 0 | 97.06 % |
Company contact information
X4 Pharmaceuticals, Inc.
61 North Beacon Street 4th floor
02134, Boston
+857 529 8300
http://www.x4pharma.comSector
Sales per region
1st Jan change | Capi. | |
---|---|---|
+8.96% | 105B | |
-1.43% | 104B | |
+4.40% | 22.94B | |
-12.15% | 22.34B | |
-4.36% | 19.25B | |
-39.98% | 17.08B | |
-10.04% | 16.96B | |
+6.79% | 14.16B | |
+38.61% | 12.63B |